Clinical Trial Update: Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

View source ↗

Summary

Clinical trial update reporting long-term use of pegvisomant (Somavert) for acromegaly as part of a regulatory post-marketing commitment; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Somavert (pegvisomant)

Snippet

Sponsor: Pfizer | Conditions: Acromegaly | Status: COMPLETED | Results posted: 2019-01-22